+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Phage Therapy Kits Market - Global Forecast 2026-2032- Product Image
Phage Therapy Kits Market - Global Forecast 2026-2032- Product Image
Sale

Phage Therapy Kits Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125433
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Phage Therapy Kits Market is projected to reach USD 520.92 Million in 2026. It is expected to continue growing at a CAGR of 21.73%, reaching USD 1.69 Billion by 2032.

Phage Therapy Kits: Executive Summary and Market Context

Phage therapy kits support the preparation, identification, characterization, and application of bacteriophages for targeted antibacterial research and therapeutic development. Their relevance is increasing as antimicrobial resistance complicates conventional treatment and as laboratories seek more adaptable tools for pathogen-specific workflows. The market spans research institutions, clinical-development programs, diagnostic settings, and specialized manufacturing environments, with demand shaped by regulatory expectations, biosafety requirements, sample quality, and the availability of validated phage libraries.

Standardization and Regulation Are Reshaping Phage Therapy Workflows

The landscape is shifting from exploratory laboratory use toward more controlled, reproducible, and clinically relevant workflows. Important developments include stronger requirements for identity and potency testing, improved host-range characterization, standardized preparation protocols, and greater attention to sterility, endotoxin control, stability, and traceability. Collaboration among hospitals, universities, biotechnology developers, and public-health organizations is also encouraging the development of shared protocols and evidence-generation frameworks. Adoption remains dependent on resolving biological variability, manufacturing consistency, intellectual-property considerations, and regulatory pathways for individualized or adaptive treatments.

Artificial Intelligence Accelerates Phage Discovery, Matching, and Quality Control

Artificial intelligence can strengthen phage therapy kit workflows by helping researchers analyze genomic data, predict phage-bacterium interactions, prioritize candidate phages, and identify resistance-associated patterns. Machine-learning tools may also support image interpretation, assay optimization, contamination detection, and batch-release documentation. However, algorithmic outputs require experimental validation because biological activity depends on host physiology, environmental conditions, phage genetics, and laboratory technique. The most practical near-term value is therefore likely to come from decision support integrated with curated datasets, laboratory information systems, and human review rather than from fully autonomous selection or clinical decision-making.

Regional Dynamics: Regulatory Readiness and Laboratory Capacity Differ Across Markets

North America benefits from advanced biomedical infrastructure, active antimicrobial-resistance research, and established translational networks, while regulatory and reimbursement considerations continue to influence clinical adoption. Europe emphasizes standardized evidence, cross-border research collaboration, and coordinated public-health responses, with variation among national implementation environments. Asia-Pacific combines strong biopharmaceutical capabilities with expanding infectious-disease research and differing levels of laboratory access. Latin America is developing capacity through academic and public-health partnerships, although procurement, validation resources, and supply-chain continuity can be uneven. The Middle East is strengthening specialized healthcare and research capabilities, while Africa presents substantial unmet need alongside constraints involving infrastructure, training, sample logistics, and sustainable financing.

Group Insights: Alliances Shape Research Coordination and Access

ASEAN countries face diverse regulatory, infrastructure, and procurement conditions, making regional protocol alignment and shared laboratory capacity valuable. BRICS members bring substantial scientific, clinical, and manufacturing capabilities but require stronger interoperability and evidence harmonization across jurisdictions. The European Union benefits from coordinated research and regulatory structures, while national implementation remains important for clinical translation. G7 economies contribute advanced research, data, and quality systems, with opportunities to coordinate antimicrobial-resistance programs. GCC countries are investing in specialized healthcare and laboratory capabilities, and NATO members may benefit from cooperation on biodefense, infection control, and resilient supply chains. Across all groups, equitable access depends on training, validated procedures, and dependable cold-chain or storage arrangements.

Country Insights: National Capabilities Create Distinct Adoption Pathways

Australia combines strong biomedical research with geographically distributed healthcare needs. Brazil and Mexico have significant infectious-disease burdens and opportunities to expand regional laboratory networks. Canada, the United States, the United Kingdom, France, Germany, Italy, and Spain offer mature research and clinical ecosystems, though each operates within distinct regulatory and reimbursement settings. China, India, Japan, and South Korea possess substantial scientific and manufacturing capabilities, with continued emphasis on domestic innovation, translational research, and quality assurance. Russia maintains relevant biomedical expertise but faces constraints linked to international collaboration and supply access. Across these countries, progress will depend on validated kit performance, clinician training, responsible data sharing, and clear pathways from laboratory evidence to patient use.

Actions for Industry Leaders: Build Trust Through Validation and Interoperability

Industry leaders should prioritize kits with transparent performance specifications, robust controls, documented biosafety procedures, and compatibility with common laboratory platforms. They should develop modular workflows that support phage isolation, screening, susceptibility testing, preparation, and quality assessment without compromising traceability. Partnerships with hospitals, reference laboratories, academic centers, and public-health agencies can improve real-world validation and identify workflow gaps. Leaders should also invest in curated genomic and phenotypic datasets, explainable analytics, staff training, resilient sourcing, and regulatory engagement. Clear separation between research-use products and clinically intended applications is essential, as is post-use surveillance for resistance, adverse events, and performance drift.

Research Methodology: Structured Synthesis of Verified Market-Relevant Evidence

This executive summary uses the supplied market category as its scope and synthesizes established, publicly documented themes concerning bacteriophage research, antimicrobial resistance, laboratory quality systems, clinical translation, regulation, and regional healthcare capacity. Insights are organized across technology, geography, economic groupings, and national operating environments. The assessment avoids unsupported numerical claims and does not infer market size, share, or forecast values. Because phage therapy remains heterogeneous across indications and jurisdictions, conclusions should be interpreted as directional findings for strategic planning and validated against current regulatory guidance, peer-reviewed evidence, procurement conditions, and local laboratory requirements.

Conclusion: Reproducibility and Evidence Will Determine Phage Kit Adoption

Phage therapy kits sit at the intersection of precision microbiology, antimicrobial-resistance management, and translational medicine. Their long-term relevance will depend less on phage discovery alone than on reproducible testing, reliable preparation, quality assurance, regulatory clarity, and practical integration into clinical and research workflows. Regional and national differences create varied routes to adoption, while artificial intelligence can improve prioritization and operational efficiency when governed by strong experimental validation. Leaders that combine technical performance with interoperability, training, responsible data practices, and durable partnerships will be best positioned to support credible progress in this field.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Phage Therapy Kits Market, by Kit Type
7.1. Introduction
7.2. Complete Kits
7.3. Consumables
7.4. Reagent Kits
7.4.1. Controls
7.4.1.1. Negative Controls
7.4.1.2. Positive Controls
7.4.2. Lysis Buffers
7.4.3. Staining Reagents
8. Phage Therapy Kits Market, by Delivery Method
8.1. Introduction
8.2. Injection
8.2.1. Intramuscular
8.2.2. Intravenous
8.2.3. Subcutaneous
8.3. Oral
8.4. Topical
9. Phage Therapy Kits Market, by Product Type
9.1. Introduction
9.2. Diagnostic Kits
9.3. Purification Kits
9.4. Quantification Kits
9.4.1. Plaque Assay Kits
9.4.2. qPCR Kits
9.4.2.1. Probe Based Kits
9.4.2.2. Sybr Green Kits
9.5. Sequencing Kits
10. Phage Therapy Kits Market, by Application
10.1. Introduction
10.2. Agricultural
10.3. Food Safety
10.4. Research
10.4.1. Basic Research
10.4.2. Commercial R And D
10.5. Therapeutic
10.5.1. Infectious Diseases
10.5.1.1. Gastrointestinal Infections
10.5.1.2. Hospital Acquired Infections
10.5.2. Oncology
10.5.3. Wound Healing
11. Phage Therapy Kits Market, by End User
11.1. Introduction
11.2. Biopharmaceutical Companies
11.3. Diagnostic Centers
11.4. Hospitals
11.5. Research Laboratories
11.5.1. Academic Institutions
11.5.2. Contract Research Organizations
11.5.2.1. Clinical Services
11.5.2.2. Preclinical Services
12. Phage Therapy Kits Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Phage Therapy Kits Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Phage Therapy Kits Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Adaptive Phage Therapeutics, Inc.
16.2. Armata Pharmaceuticals, Inc.
16.3. BiomX, Inc.
16.4. ContraFect Corporation
16.5. Eliava BioPreparations LTD
16.6. Eligo Bioscience SAS
16.7. Fixed-Phage Limited
16.8. Intralytix, Inc.
16.9. iNtRON Biotechnology, Inc.
16.10. Locus Biosciences, Inc.
16.11. Micreos BV
16.12. Microgen
16.13. Phagelux, Inc.
16.14. Pherecydes Pharma SAS
16.15. Technophage
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Phage Therapy Kits Market, Years Considered for the Study
FIGURE 2. Global Phage Therapy Kits Market, Research Design
FIGURE 3. Global Phage Therapy Kits Market, Research Framework
FIGURE 4. Global Phage Therapy Kits Market, Data Triangulation
FIGURE 5. Global Phage Therapy Kits Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Phage Therapy Kits Market Size, by Kit Type, 2025 vs 2032 (%)
FIGURE 7. Global Phage Therapy Kits Market Size, by Kit Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Phage Therapy Kits Market Size, by Delivery Method, 2025 vs 2032 (%)
FIGURE 9. Global Phage Therapy Kits Market Size, by Delivery Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Phage Therapy Kits Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 11. Global Phage Therapy Kits Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Phage Therapy Kits Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Phage Therapy Kits Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Phage Therapy Kits Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Phage Therapy Kits Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Phage Therapy Kits Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Phage Therapy Kits Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Phage Therapy Kits Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Phage Therapy Kits Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Phage Therapy Kits Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Phage Therapy Kits Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Phage Therapy Kits Market Segmentation & Coverage
TABLE 2. Global Phage Therapy Kits Market Size, 2017-2032 (USD Million)
TABLE 3. Global Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 4. Global Complete Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Complete Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Complete Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Reagent Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Reagent Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Reagent Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Controls Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Controls Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Controls Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Negative Controls Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Negative Controls Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Negative Controls Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Positive Controls Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Positive Controls Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Positive Controls Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Lysis Buffers Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Lysis Buffers Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Lysis Buffers Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Staining Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Staining Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Staining Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 29. Global Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 48. Global Diagnostic Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Diagnostic Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Diagnostic Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Purification Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Purification Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Purification Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Quantification Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Quantification Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Quantification Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Plaque Assay Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Plaque Assay Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Plaque Assay Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global qPCR Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global qPCR Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global qPCR Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Probe Based Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Probe Based Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Probe Based Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Sybr Green Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Sybr Green Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Sybr Green Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Sequencing Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Sequencing Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Sequencing Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 73. Global Agricultural Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Agricultural Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Agricultural Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Food Safety Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Food Safety Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Food Safety Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Basic Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Basic Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Basic Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Commercial R And D Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Commercial R And D Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Commercial R And D Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Therapeutic Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Therapeutic Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Therapeutic Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Gastrointestinal Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Gastrointestinal Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Gastrointestinal Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Hospital Acquired Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Hospital Acquired Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Hospital Acquired Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Wound Healing Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Wound Healing Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Wound Healing Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Global Biopharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Biopharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Biopharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Research Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Research Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Research Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Academic Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Academic Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Academic Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Clinical Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Clinical Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Clinical Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Preclinical Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Preclinical Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Preclinical Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Phage Therapy Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Phage Therapy Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 148. North America Phage Therapy Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. North America Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 150. North America Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 151. North America Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 152. North America Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 153. North America Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 154. North America Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. North America Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 156. North America Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 157. North America Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. North America Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 159. North America Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 160. North America Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 161. North America Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. North America Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 163. North America Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 164. Latin America Phage Therapy Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Latin America Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 166. Latin America Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 167. Latin America Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 168. Latin America Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 169. Latin America Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 170. Latin America Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 171. Latin America Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 172. Latin America Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 173. Latin America Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Latin America Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 175. Latin America Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 176. Latin America Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 177. Latin America Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Latin America Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 179. Latin America Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 180. Europe Phage Therapy Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Europe Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 182. Europe Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 183. Europe Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 184. Europe Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 185. Europe Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 186. Europe Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 187. Europe Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 188. Europe Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 189. Europe Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Europe Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 191. Europe Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 192. Europe Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 193. Europe Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Europe Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 195. Europe Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 196. Middle East Phage Therapy Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Middle East Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 198. Middle East Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 199. Middle East Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 200. Middle East Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 201. Middle East Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 202. Middle East Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 203. Middle East Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 204. Middle East Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 205. Middle East Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. Middle East Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 207. Middle East Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 208. Middle East Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 209. Middle East Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Middle East Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 211. Middle East Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 212. Africa Phage Therapy Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 213. Africa Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 214. Africa Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 215. Africa Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 216. Africa Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 217. Africa Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 218. Africa Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. Africa Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 220. Africa Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 221. Africa Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. Africa Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 223. Africa Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 224. Africa Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 225. Africa Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Africa Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 227. Africa Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 228. Global Phage Therapy Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. ASEAN Phage Therapy Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 230. ASEAN Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 231. ASEAN Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 232. ASEAN Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 233. ASEAN Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 234. ASEAN Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 235. ASEAN Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 236. ASEAN Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 237. ASEAN Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 238. ASEAN Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. ASEAN Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 240. ASEAN Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 241. ASEAN Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 242. ASEAN Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. ASEAN Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 244. ASEAN Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 245. GCC Phage Therapy Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 246. GCC Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 247. GCC Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 248. GCC Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 249. GCC Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 250. GCC Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 251. GCC Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 252. GCC Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 253. GCC Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 254. GCC Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. GCC Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 256. GCC Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 257. GCC Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 258. GCC Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. GCC Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 260. GCC Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 261. European Union Phage Therapy Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 262. European Union Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 263. European Union Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 264. European Union Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 265. European Union Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 266. European Union Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 267. European Union Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 268. European Union Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 269. European Union Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 270. European Union Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 271. European Union Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 272. European Union Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 273. European Union Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 274. European Union Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. European Union Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 276. European Union Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 277. BRICS Phage Therapy Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 278. BRICS Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 279. BRICS Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 280. BRICS Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 281. BRICS Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 282. BRICS Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 283. BRICS Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 284. BRICS Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 285. BRICS Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 286. BRICS Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 287. BRICS Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 288. BRICS Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 289. BRICS Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 290. BRICS Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 291. BRICS Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 292. BRICS Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 293. G7 Phage Therapy Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 294. G7 Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 295. G7 Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 296. G7 Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 297. G7 Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 298. G7 Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 299. G7 Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 300. G7 Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 301. G7 Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 302. G7 Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 303. G7 Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 304. G7 Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 305. G7 Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 306. G7 Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 307. G7 Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 308. G7 Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 309. NATO Phage Therapy Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 310. NATO Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 311. NATO Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 312. NATO Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 313. NATO Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 314. NATO Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 315. NATO Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 316. NATO Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 317. NATO Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 318. NATO Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 319. NATO Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 320. NATO Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 321. NATO Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 322. NATO Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. NATO Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 324. NATO Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 325. Global Phage Therapy Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 326. United States Phage Therapy Kits Market Size, 2017-2032 (USD Million)
TABLE 327. United States Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 328. United States Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 329. United States Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 330. United States Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 331. United States Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 332. United States Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 333. United States Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 334. United States Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 335. United States Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 336. United States Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 337. United States Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 338. United States Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 339. United States Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 340. United States Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 341. United States Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 342. Canada Phage Therapy Kits Market Size, 2017-2032 (USD Million)
TABLE 343. Canada Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 344. Canada Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 345. Canada Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 346. Canada Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 347. Canada Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 348. Canada Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 349. Canada Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 350. Canada Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 351. Canada Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 352. Canada Phage Therapy Kits Market Size, by Research, 2017-2032 (USD Million)
TABLE 353. Canada Phage Therapy Kits Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 354. Canada Phage Therapy Kits Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 355. Canada Phage Therapy Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 356. Canada Phage Therapy Kits Market Size, by Research Laboratories, 2017-2032 (USD Million)
TABLE 357. Canada Phage Therapy Kits Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 358. Mexico Phage Therapy Kits Market Size, 2017-2032 (USD Million)
TABLE 359. Mexico Phage Therapy Kits Market Size, by Kit Type, 2017-2032 (USD Million)
TABLE 360. Mexico Phage Therapy Kits Market Size, by Reagent Kits, 2017-2032 (USD Million)
TABLE 361. Mexico Phage Therapy Kits Market Size, by Controls, 2017-2032 (USD Million)
TABLE 362. Mexico Phage Therapy Kits Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 363. Mexico Phage Therapy Kits Market Size, by Injection, 2017-2032 (USD Million)
TABLE 364. Mexico Phage Therapy Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 365. Mexico Phage Therapy Kits Market Size, by Quantification Kits, 2017-2032 (USD Million)
TABLE 366. Mexico Phage Therapy Kits Market Size, by qPCR Kits, 2017-2032 (USD Million)
TABLE 367. Mexico Phage Therapy Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 36

Companies Mentioned

  • Adaptive Phage Therapeutics, Inc.
  • Armata Pharmaceuticals, Inc.
  • BiomX, Inc.
  • ContraFect Corporation
  • Eliava BioPreparations LTD
  • Eligo Bioscience SAS
  • Fixed-Phage Limited
  • Intralytix, Inc.
  • iNtRON Biotechnology, Inc.
  • Locus Biosciences, Inc.
  • Micreos BV
  • Microgen
  • Phagelux, Inc.
  • Pherecydes Pharma SAS
  • Technophage

Related Topics

Related Reports

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 181 Pages
  • Global
From
Phage Therapy Market Outlook 2026-2034: Market Share, and Growth Analysis by Phage Type (Natural lytic phages, Genetically engineered / synthetic phages, Phage cocktails, Endolysins & phage-derived enzymes), Targeted Bacteria, Mode, Application - Product Image

Phage Therapy Market Outlook 2026-2034: Market Share, and Growth Analysis by Phage Type (Natural lytic phages, Genetically engineered / synthetic phages, Phage cocktails, Endolysins & phage-derived enzymes), Targeted Bacteria, Mode, Application

  • Report
  • 160 Pages
  • Global
From
Phage Therapy - Global Strategic Business Report - Product Image

Phage Therapy - Global Strategic Business Report

  • Report
  • 149 Pages
  • Global
From
Phage Therapy Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Phage Therapy Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Klebsiella Pneumoniae Infection Market in India - Product Image

Klebsiella Pneumoniae Infection Market in India

  • Report
  • 150 Pages
  • India
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.